
| 姓 名: | 張夢雲 |
|---|---|
| 學 科: | 血液與免疫細胞再生 |
| 電話/傳真: | +86-10-64808780 / |
| 電子郵件: | zhangmengyun@ioz.ac.cn |
| 通訊地址: | 北京市朝陽區大屯路甲3號 中國科學院幹細胞與再生醫學創新研究院 100101 |
| 更多信息: | 血液與免疫細胞再生研究組 |
簡曆介紹:
2023年8月-至今,必威精装版app西汉姆联 ,副研究員
2018年8月-2023年8月,廣州醫科大學,教授
2013年9月-2018年7月,中國科學院大學廣州生物醫藥與健康研究院,細胞生物學,博士
2009年9月-2013年6月,山西農業大學,生物科學,學士
研究領域:
主要從事功能性免疫細胞再生研究,利用體內誘導譜係重編程途徑及多能幹細胞定向分化途徑探索免疫細胞再生與功能重建。首次發現轉錄因子Hoxb5可以誘導B細胞體內重編程為功能性T淋巴細胞,建立了在體重編程再生功能性T細胞新技術;實現多能幹細胞誘導分化來源天然淋巴細胞(ILC)及造血免疫多譜係細胞在體移植重建;參與開發臍帶血來源CD34+造血幹祖細胞及人多能幹細胞大規模誘導獲得CAR-iNK細胞新方法。相關的學術成果發表在Nature Immunology、Cell Stem Cell、Nature Biomedical Engineering、Journal of Hematology & Oncology、Cell Reports等國際學術期刊上。
社會任職:
獲獎及榮譽:
承擔科研項目情況:
2025年-2028年,國家自然科學基金麵上項目,主持
2020年-2022年,國家自然科學基金青年科學基金C類,主持
2019年-2023年,國家重點研發計劃項目,項目骨幹
代表論著:
1. Zhiqian Wang; Leqiang Zhang; Dehao Huang; Chengxiang Xia; Qitong Weng; Yunqing Lin; Yanhong Liu; Zhenghan Liu; Ruowen Yi; Fan Zhang; Yaoqin Zhao; Jiaxin Wu; Hanmeng Qi; Lijuan Liu; Yiyuan Shen; Yi Chen; Yanping Zhu; Tongjie Wang*; Mengyun Zhang*; Fangxiao Hu*; Jinyong Wang*; Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models. Cell Stem Cell, 2026, 33(3): 405-420. 共同通訊
2. Fangxiao Hu; Jianhuan Li; Yao Wang; Yunqing Lin; Jingliao Zhang; Jiacheng Xu; Xiujuan Zheng; Qitong Weng; Xiaofei Liu; Yang Geng; Hongling Wu; Lijuan Liu; Huan Peng; Bingyan Wu; Dehao Huang; Chengxiang Xia; Tongjie Wang; Xin Du; Hui Zeng; Fang Dong; Yingchi Zhang; Xiaofan Zhu*; Mengyun Zhang*; Jinyong Wang*; Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy. Nature Biomedical Engineering, 2025, 1-20. 共同通訊
3. Yunqing Lin; Ziyun Xiao; Fangxiao Hu; Xiujuan Zheng; Chenyuan Zhang; Yao Wang; Yanhong Liu; Dehao Huang; Zhiqian Wang; Chengxiang Xia; Qitong Weng; Leqiang Zhang; Yaoqin Zhao; Hanmeng Qi; Yiyuan Shen; Yi Chen; Fan Zhang; Jiaxin Wu; Pengcheng Liu; Jiacheng Xu; Lijuan Liu; Yanping Zhu; Jingliao Zhang; Wenbin Qian; Aibin Liang; Xiaofan Zhu; Tongjie Wang*; Mengyun Zhang*; Jinyong Wang*; Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies. Journal of Hematology & Oncology, 2025, 18(1). 共同通訊
4. Huan Peng#; Yunqing Lin#; Fangxiao Hu; Cui Lv; Bingyan Wu; Qitong Weng; Lijuan Liu; Chengxiang Xia; Xiaofei Liu; Yalan Zhao; Qi Zhang; Yang Geng; Mengyun Zhang*; Jinyong Wang*; Prolonged generation of multi-lineage blood cells in wild type animals from pluripotent stem cells. Stem Cell Reports, 2023.03,18(3):720-735. 共同通訊
5. Jiapin Xiong#; Yalan Zhao#; Yunqing Lin; Lebei Chen; Qitong Weng; Chuanping Shi; Xiaofei Liu; Yang Geng; Lijuan Liu; Jinyong Wang*; Mengyun Zhang*; Identification and characterization of innate lymphoid cells generated from pluripotent stem cells. Cell Reports, 2022.11, 41(5):111569. 最後通訊
6. Mengyun Zhang#; Yong Dong#; Fangxiao Hu#; Dan Yang; Qianhao Zhao; Cui Lv; Ying Wang; Chengxiang Xia; Qitong Weng; Xiaofei Liu; Chen Li; Peiqing Zhou; TongjieWang; Yuxian Guan; Rongqun Guo; Lijuan Liu; Yang Geng; Hongling Wu; Juan Du; Zheng Hu; Sheng Xu; Jiekai Chen; Aibin He; Bing Liu; Demin Wang; Yong-Guang Yang; Jinyong Wang*; Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes. Nature Immunology, 2018.03, 19(3): 279~290. 第一作者
專利:
寫給考生的話:

